ConductScience.org, home

Paper4040355

Intolerance to cisplatin--a case report.

Umbach GE and 3 others. Arch Gynecol, 1985. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Intolerance to cisplatin--a case report. Papers, record 4040355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4040355

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intolerance to cisplatin--a case report.
PubMed
Journal
Arch Gynecol
PubMed
Year
1985
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.21
iCite
Revised in PubMed
2019-10-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Umbach GEG E
2von Matthiessen HH
3Wirth GG
4Goerz GG

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
Drug HypersensitivityMajor topic
Drug Tolerance
Female
Humans
Middle Aged

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1387223Toxic effects of cis-dichlorodiammineplatinum(II) in man.Cancer Treat Rep1979https://conductscience.org/library/papers/387223PubMed
2856437High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.Cancer1977https://conductscience.org/library/papers/856437PubMed
37188679Toxicity of cis-diamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydration.Cancer1980https://conductscience.org/library/papers/7188679PubMed
4291484Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.Cancer Treat Rep1979https://conductscience.org/library/papers/291484PubMed
5574057Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.Cancer Treat Rep1979https://conductscience.org/library/papers/574057PubMed
691439Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial.Cancer Treat Rep1979https://conductscience.org/library/papers/91439PubMed
77004302Hypersensitivity reactions to cancer chemotherapeutic agents.Ann Intern Med1981https://conductscience.org/library/papers/7004302PubMed
84187030Platinum and platinosis. Allergy and histamine release due to some platinum salts.Arch Environ Health1969https://conductscience.org/library/papers/4187030PubMed
950881Atopic hypersensitivity to cis-dichlorodiammineplatinum(II) and other platinum complexes.Cancer Res1975https://conductscience.org/library/papers/50881PubMed
1087272Successful re-treatment with cis-dichlorodiammineplatinum(II) after apparent allergic reactions.Cancer Treat Rep1979https://conductscience.org/library/papers/87272PubMed
116455280[Non allergic skin reactions of drugs (author's transl)].Derm Beruf Umwelt1981https://conductscience.org/library/papers/6455280PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4040355

GET https://conductscience.org/api/papers/v1/4040355/authors